Hematology Diagnostics Industry Forecast to Grow from $4.06 Billion in 2024 to $5.93 Billion by 2030 - Abbott, Beckman Coulter, Sysmex Corp, Roche, and Siemens Healthineers Lead the Competition
21 janv. 2025 04h05 HE
|
Research and Markets
Dublin, Jan. 21, 2025 (GLOBE NEWSWIRE) -- The "Hematology Diagnostics Market Size, Share & Trends Analysis by Product, Test, End Use, and Region, 2025-2030" report has been added to ...
Leukapheresis Market Outlook Report 2025: Leukapheresis Market Projected to Surge to USD 672.4 Million by 2034, Driven by Technological Advances and Rising Demand for Blood Cancers Treatment
07 janv. 2025 08h45 HE
|
Research and Markets
Dublin, Jan. 07, 2025 (GLOBE NEWSWIRE) -- The "Leukapheresis Market by Product, by Application, by End-User, and By Region" report has been added to ResearchAndMarkets.com's offering.The global...
Vor Bio Announces $55.6 Million Private Placement
27 déc. 2024 09h00 HE
|
Vor Biopharma
Intend to announce updated clinical data from Phase 1/2 VBP301 trial of VCAR33ALLO in the first half of 2025 and updated clinical data from Phase 1/2a VBP101 trial of trem-cel in combination with...
Vor Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback from FDA Regarding Registrational Trial Design
09 déc. 2024 07h30 HE
|
Vor Biopharma
Preliminary data suggests improved relapse-free survival compared to published groups of acute myeloid leukemia (AML) patients at high risk of relapse post-transplantTrem-cel + Mylotarg continue to...
Cancer Monoclonal Antibodies Market to Grow at a 18.4% CAGR through 2031 | SkyQuest Technology
09 déc. 2024 07h10 HE
|
SkyQuest Technology Consulting Pvt. Ltd.
Westford, USA, Dec. 09, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that the cancer monoclonal antibodies market size will attain a value of USD 337.92 billion by 2031, with a CAGR of 18.4% over the...
Smart Immune et CELLforCURE by SEQENS s'associent pour industrialiser la production des lots cliniques de SMART101
03 déc. 2024 00h00 HE
|
Smart Immune
COMMUNIQUÉ DE PRESSE | Paris, France - 3 décembre 2024 Smart Immune, société de biotechnologie en stade clinique, et CELLforCURE by SEQENS, entreprise de développement et de fabrication en...
Smart Immune and CELLforCURE by SEQENS Partner to Industrialize SMART101 Clinical Batches Manufacturing
03 déc. 2024 00h00 HE
|
Smart Immune
PRESS RELEASE | Paris, France – December 3, 2024 Smart Immune, a clinical-stage biotechnology company, and CELLforCURE by SEQENS, a Contract Development and Manufacturing Organization (CDMO) for...
9-Year Old Rare Blood Disorder Survivor Meets Lifesaving Donor at Gift of Life Marrow Registry Gala
22 nov. 2024 15h37 HE
|
Gift of Life Marrow Registry
Miami Beach Event Honored Emilio Estefan, Jr., Vice Mayor Alex Fernandez and Boucher Brothers for their Distinguished Advocacy BOCA RATON, Fla., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Gift of Life...
Vor Bio to Participate in the Stifel 2024 Healthcare Conference
12 nov. 2024 08h00 HE
|
Vor Biopharma
CAMBRIDGE, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in a fireside chat and host...
Vor Bio Reports Third Quarter 2024 Financial Results and Provides Company Update
07 nov. 2024 16h05 HE
|
Vor Biopharma
Company to present trem-cel + Mylotarg clinical data update at American Society of Hematology (ASH) 2024 annual meetingHan Choi, M.D., LL.M, seasoned healthcare institutional investor, appointed as...